Objective-Deleted in malignant brain tumors 1 (DMBT1) belongs to the scavenger receptor cysteine-rich superfamily of proteins and is implicated in innate immunity, cell polarity, and differentiation. Here we studied the role of DMBT1 in endothelial cells. Methods and Results-DMBT1 was secreted into the extracellular matrix (ECM) by endothelial cells in vitro and in situ and the presence of DMBT1 in the ECM increased endothelial cell adherence. Endothelial cell-derived DMBT1 associated with galectin-3 (coprecipitation), and human recombinant DMBT1 bound EGF, vascular endothelial growth factor and Delta-like (Dll) 4 (specific ELISAs). Compared to cells from wild-type mice, endothelial cells from DMBT1 Ϫ/Ϫ mice demonstrated reduced migration, proliferation, and tube formation. In vivo recovery from hindlimb ischemia was attenuated in DMBT1 Ϫ/Ϫ animals as was vascular endothelial growth factor -induced endothelial sprouting from isolated aortic rings; the latter response could be rescued by the addition of recombinant DMBT1. The Notch pathway is involved in multiple aspects of vascular development, including arterial-venous differentiation and we found that endothelial cells from DMBT1 Ϫ/Ϫ mice expressed more EphrinB2 than cells from wild-type mice. Levels of Dll1, Dll4, Hes1, Hey1, and EphB4, on the other hand, were decreased. Conclusion-Taken together, the results of this study indicate that DMBT1 functions as an important endotheliumderived ECM protein that is able to bind angiogenic factors and promote adhesion, migration, proliferation, and angiogenesis as well as vascular repair. Mechanistically, DMBT1 interacts with galectin-3 and modulates the Notch signaling pathway as well as the differential expression of ephrin-B2 and EphB4. (Arterioscler Thromb Vasc Biol. 2012;32:442-448.)
T he mechanisms that regulate angiogenesis and vascular differentiation are complex but include interactions between the endothelium and the extracellular matrix (ECM). 1 Human deleted in malignant brain tumors 1 (DMBT1; also known as lung glycoprotein-340) is a secreted high molecular weight pattern recognition molecule belonging to the scavenger receptor cysteine-rich superfamily that binds polyphosphorylated and -polysulfated structures found on bacterial and viral surfaces as well as in the ECM. As its name suggests the DMBT1 gene was presumed to play a role in tumor suppression, 2 however it now seems that DMBT1 may play a more complex role in tumorigenesis than originally thought and that its actions differ from that of a conventional tumor suppressor gene. 3 DMBT1 is expressed by several cell types and the polymerization of hensin, the rabbit orthologue of DMBT1, and its interaction in the ECM with galectin-3 reportedly modulates the polarity of epithelial cells. 4 The molecular mechanisms involved are unclear but the activation of integrin ␣v␤1 triggers the secretion of hensin into the ECM where it polymerizes, binds integrin ␣6, and stimulates cell differentiation. 5 Integrins with a ␤1 subunit are receptors for ECM proteins, such as the laminins and fibronectin, and play an important role in angiogenesis. 6 Given that DMBT1 has been detected in/on endothelial cells in samples from patients, 7 it is tempting to suggest a link between integrin-induced DMBT1 deposition and angiogenesis. The aim of the present study was therefore to assess the expression of DMBT1 in the endothelium and to determine its role in angiogenesis and vascular repair.
Materials and Methods
A detailed description of all of the materials, antibodies and standard methods used appear in Supplemental Materials and Methods, available online at http://atvb.ahajournals.org.
Animals
Male wild-type and DMBT1 Ϫ/Ϫ mice (C57BL/6 background), 8 were bred at the central animal facility at the German Cancer Research Center Heidelberg. All animal experiments were approved by the Regierungspräsidium Karlsruhe (license G172-09).
Hindlimb Ischemia
Hindlimb ischemia was induced as outlined. 9 Limb perfusion was measured with a laser Doppler imager every three to four days (Moor Instruments Ltd, Millwey, England). After 14 days the mice were killed and the M. adductor and M. semimembranosus were removed for analysis.
Aortic Ring Assay
Aortae from wild-type and DMBT1 Ϫ/Ϫ mice were removed, cleaned, and embedded in a collagen gel (collagen type I, BD Biosciences, Heidelberg, Germany) in a 48-well plate containing MCDB 131 medium (Gibco/Invitrogen, Karlsruhe, Germany) supplemented with murine serum (2.5%) from the donor animals. After 24 hours, murine vascular endothelial growth factor (VEGF) (30 ng/mL) and/or human recombinant DMBT1 (100 ng/mL) were added and the tube-like structures were allowed to develop over 7 days. Thereafter, the samples were fixed (4% paraformaldehyde) and endothelial cells were visualized using antibodies against CD31.
Cell Culture
Murine endothelial cells from wild-type and DMBT1 Ϫ/Ϫ mice and human umbilical vein endothelial cells were isolated and cultured as described previously. 10 Murine endothelial cells were used up to passage 9 while first passage human endothelial cells were used throughout. The use of human material in this study conforms to the principles outlined in the Declaration of Helsinki and the isolation of endothelial cells was approved by the ethic committee at the Goethe University.
Statistics
Data are expressed as the meanϮSEM, and statistical evaluation was performed using Student t-test for unpaired data, 1-way ANOVA followed by a Bonferroni t-test, or ANOVA for repeated measures where appropriate. Values of PϽ0.05 were considered statistically significant.
Results

Localization and Regulation of DMBT1 in Endothelial Cells
To determine the vascular localization of DMBT1 we compared its expression with that of endothelial (FITC-lectin) and smooth muscle cell (␣-actin) markers in murine tissues. In the hindlimb adductor muscle; DMBT1 surrounded muscle fibers and was detected in close proximity to capillary endothelial cells as well as small arteries ( Figure 1A ). In the developing retina (postnatal day 5) DMBT1 was detected at the leading edge of the capillary network and was closely associated with the filipodia that extended from tip cells. DMBT1 was also evident in the stalk cells of the retina where it seemed to be adjacent to, rather than within, the endothelium ( Figure 1B) , a finding consistent with the fact that DMBT1 is a secreted protein. In en face preparations of the murine aorta, DMBT1 was detected when the endothelium was intact but not once the endothelial layer was removed mechanically, indicating the endothelial association of the protein ( Figure 1C ). No DMBT1 was detected in samples from DMBT1 Ϫ/Ϫ mice ( Figure 1C and Supplementary Figure I) .
Primary cultures of human umbilical vein endothelial cells expressed DMBT1; low levels were detected in the cell cytosol with the majority of the protein being in the ECM (Figure 2A ). Consistent with the fact that it is highly glycosylated, DMBT1 was detected by Western blotting as a diffuse 340 kDa band. Galectin-3, which interacts with DMBT1 in other tissues to promote DMBT1 polymerization, 11 was also expressed by the endothelium, 12 and could be coprecipitated with DMBT1 from confluent cultures of human endothelial cells and vice versa ( Figure 2B ).
Effect of DMBT1 on Endothelial Cell Adhesion
The effect of DMBT1 on endothelial cell adhesion and migration was studied using DMBT1-containing and -depleted ECM generated by wild-type or DMBT1 Ϫ/Ϫ lung endothelial cells. This procedure was chosen in preference to plating cells on human recombinant DMBT1 (hrDMBT1) as the native protein is highly glycosylated, a modification that affects its function including its association with galectin-3. 13 In the endothelial cells plated onto DMBT1-containing ECM, paxillin and phosphorylated focal adhesion kinase (FAK) colocalized in clusters at the cell membrane. However, in cells plated onto DMBT1-deficient ECM, phosphorylated FAK was only detected close to the nucleus ( Figure 3A ). Moreover, fewer endothelial cells adhered to the DMBT1-depleted ECM ( Figure 3B ).
The function of DMBT1 was further addressed by determining the attachment of cells to culture dishes coated with hrDMBT1. Endothelial cells adhered to hrDMBT1-coated surfaces to a similar degree as to laminin-and fibronectincoated surfaces ( Figure 3C ). The dependency of hrDMBT1mediated cell adhesion on divalent cations (an index of integrin-mediated cell adhesion) was similar to that of laminin but less than that observed when cells were plated onto fibronectin. Interestingly, endothelial cells from DMBT1 Ϫ/Ϫ mice displayed a significantly stronger adhesion to hrDMBT1, laminin, and fibronectin in the presence but not in the absence of divalent cations ( Figure 3D, 3E ). We found no significant difference in the expression of ␣v or ␤1 integrins in wild-type versus DMBT1 Ϫ/Ϫ endothelial cells; however, the expression of ␤3 integrin was significantly lower in endothelial cells from DMBT1 Ϫ/Ϫ mice (Supplementary Figure II) .
Binding of hrDMBT1 to EGF, VEGF, and Dll4
Several ECM constituents are able to bind growth factors and thus modulate angiogenesis. Because DMBT1 has a repetitive structure with multiple binding sites we hypothesized that it may also be able to sequester growth factors. Indeed, hrDMBT1 was able to bind to EGF (Supplementary Figure  IIIA) and VEGF (Supplementary Figure IIIB) . Moreover, we also found that hrDMBT1 bound the Notch ligand Delta-like Figure IIIC) . Because all of these factors are involved in angiogenesis it is feasible that their association with DMBT1 can effectively increase their local concentrations thus promoting the vascular response. The latter interactions were disturbed by heparan sulfate (Supplementary Figure IIID ).
(Dll4; Supplementary
Role of DMBT1 in Endothelial Cell Migration and Angiogenesis In Vitro
We next compared the ability of endothelial cells from wild-type and DMBT1 Ϫ/Ϫ mice to migrate in a scratchwound assay as well as to proliferate and form tube-like structures. Although wild-type endothelial cells migrated to cover approximately 50% of the wound area after 22 hours, the migration of endothelial cells from DMBT1 Ϫ/Ϫ mice was markedly delayed (Supplementary Figure IVA) . Moreover, although endothelial cells from wild-type mice proliferated well in the presence of 20% FCS, responses were attenuated in cells from Dmbt1 Ϫ/Ϫ mice (Supplementary Figure IVB) without any detectable increase in apoptosis.
The attenuated endothelial cell proliferation and migration were also reflected in an impaired ability to form tube-like structures on Matrigel in response to VEGF ( Figure 4A ). This phenomenon was not restricted to endothelial cells in culture as the formation of endothelial cell (CD-31 positive) capillary sprouts was also attenuated in aortic rings from DMBT1 Ϫ/Ϫ mice following either incubation with solvent or VEGF ( Figure 4B ). In a rescue experiment we next determined whether or not the addition of hrDMBT1 could restore responsiveness to VEGF. Recombinant DMBT1, either alone or in combination with VEGF, slightly enhanced sprouting in rings from wild-type mice ( Figure 4B ). In aortic rings from DMBT1 Ϫ/Ϫ mice, hrDMBT1 alone was without significant effect but it did restore responsiveness to VEGF to levels similar to that observed in wild-type tissue.
Role of DMBT1 in Angiogenesis In Vivo
Next we determined the ability of DMBT1 Ϫ/Ϫ mice to recover from hindlimb ischemia. This model seemed particularly appropriate because DMBT1 was detected in skeletal muscle capillaries. In wild-type animals, femoral artery ligation compromised hindlimb blood flow (laser Doppler measurements), which recovered to approximately 75% of preligation values within 14 days. Although limb perfusion was comparable in wild-type and DMBT1 Ϫ/Ϫ mice prior to ligation, blood flow in the ischemic limb recovered more slowly with a maximal recovery of only 25% after 2 weeks ( Figure 5A ). This correlated with the impaired vascularization (arterial and capillary numbers) of the M. adductor in hindlimbs from dmbt1 Ϫ/Ϫ mice ( Figure 5B ).
DMBT1 and Notch Signaling
Notch signaling plays a crucial role in reparative angiogenesis and changes in the expression of the Notch ligands, Dll1 and Dll4, have been reported to occur during postischemic angiogenesis. 14, 15 Given that hrDMBT1 was able to bind Dll4, we assessed the consequences of DMBT1 deletion on the expression of components of the Notch signaling cascade. Although Notch1 expression was slightly increased in DMBT1 Ϫ/Ϫ endothelial cells ( Figure 6A ), the expression of the ligands Dll1 and Dll4 mRNA was attenuated as was the expression of Hes1 and Hey1, 2 downstream effectors of the Notch signaling cascade.
The Notch pathway is involved in multiple aspects of vascular development, including arterial-venous differentiation, therefore we determined the consequences of DMBT1deletion on the expression of ephrin-B2 and EphB4, 2 proteins differentially expressed in arterial and venous endothelium, respectively. 16 Murine lung microvascular endothelial cells expressed both ephrin-B2 and EphB4 but whereas EphB4 levels were consistently higher in wild-type than in DMBT1 Ϫ/Ϫ cells, the reverse was true for ephrin-B2 ( Figure  6B) . Similarly, decreased levels of EphB4 were detected in vivo in skeletal muscle capillaries ( Figure 6C ). Moreover, while coating mouse lung endothelial cells onto hrDMBT1 had no effect on EphB4 levels, it increased EphB4 levels in DMBT1 Ϫ/Ϫ cells ( Figure 6D ). 
Discussion
The results of the present investigation demonstrate that DMBT1 is an important vascular ECM protein, promoting endothelial cell adhesion, migration, proliferation and reparative angiogenesis. To our knowledge, this is the first time that a protein of the scavenger receptor cysteine-rich super family has been linked to these processes. Although the precise molecular mechanisms underlying these effects remain to be determined in detail, we found that DMBT1 interacts with galectin-3, EGF, VEGF, and Dll4. Moreover, the genetic deletion of DMBT1 attenuates Notch signaling and thus differentially affects the expression of ephrin-B2 and EphB4.
Almost nothing is known about the vascular actions of DMBT1. Immunohistochemical analysis of heart tissue previously revealed sporadic DMBT1 expression in/on endothelial cells as well as in the heart valves of patients with bacterial endocarditis 7 ; which fits well with reports linking DMBT1 with inflammation and innate immune responses in different organs. 17, 18 Our data indicate that DMBT1 is secreted by endothelial cells to the ECM under normal physiological conditions in vitro and in vivo, and that human DMBT1 is similar to hensin (rabbit DMBT1) with regard to its interaction with galectin-3, a ␤-galactoside-binding lectin. The interaction of the 2 proteins is likely to be required for their vascular effects as not only does the deletion of DMBT1 attenuate angiogenesis and vascular repair (present study) but galectin 3 inhibition and downregulation also reduce VEGF-and basic fibroblast growth factor-mediated angiogenesis in vitro, and angiogenic responses are reduced in galectin-3 Ϫ/Ϫ animals. 19 Mechanis-tically, the angiogenic effects of galectin-3 have been attributed to binding; via its carbohydrate recognition domain, to the GnTV synthesized N-glycans of integrin ␣v␤3, to induce its clustering. 19 Although we did not address the direct interaction of DMBT1 with integrins we did observe that the expression of ␤3 integrin was attenuated in endothelial cells from DMBT1 Ϫ/Ϫ mice. More recently galectin-3 was also reported to modulate angiogenesis in human endothelial cells by retaining the cell surface expression of the VEGF receptor 2. 20 However, whether or not DMBT1 also affects VEGF receptor cycling remains to be determined.
DMBT1 has a repetitive structure with 14 SRCR domains and multiple binding sites making it likely that 1 molecule DMBT1 binds a number of other molecules. 21 Thus binding to galectin-3 may not account for all of the effects of DMBT1 and its ability to bind EGF, VEGF, and Dll4 and may account for some of its effects on angiogenesis and vascular repair. This is of relevance as the interaction of growth factors with the ECM is one key mechanism thought to regulate the actions of growth factors, including VEGF. 22 It is thus tempting to speculate that interaction with DMBT1 may be a means of increasing the local concentrations of angiogenic growth factors. The results of the aortic ring assays indicate that DMBT1 is required for normal responsiveness to VEGF as the sprouting response to VEGF could be restored in DMBT1 Ϫ/Ϫ vessels by the addition of VEGF and hrDMBT1 but not by hrDMBT1 alone. Interestingly, all of the growth factors tested are glycosylated and contain disulfide bonds, implicating that these characteristics might be involved in the binding to DMBT1. 18 The Notch ligand, Dll4, is upregulated in response to hindlimb ischemia in mice and localized at the forefront of sprouting capillaries. 15 Functionally Dll4 is required for angiogenesis and its inhibition by the intramuscular injection of an adenovirus encoding the soluble form of Dll4 extracellular domain precipitates the formation of a disorganized, low-perfused capillary network in ischemic muscles. 15 We found that the deletion of DMBT1 elicited similar effects as those described following Dll4 inhibition, ie, attenuated capillary formation and markedly attenuated recovery of blood flow in ischemic hindlimbs. Moreover, DMBT1 deletion was found to have marked consequences on Notch signaling. Indeed, compared to cells from wild-type mice, endothelial cells from DMBT1 Ϫ/Ϫ mice showed attenuated expression of the Notch regulated genes Hes1 and Hey1. To further assess the link between DMBT1 and Notch signaling, we studied the consequences of DMBT1 deletion on ephrin-B2 and EphB4, 2 proteins that are involved in arteriovenous differentiation and previously reported to be regulated by Notch. 14, 16, 23, 24 Indeed, we observed that the deletion of DMBT1 altered the expression of both markers, ie, decreased EphB4 while increasing ephrin-B2 expression in murine lung endothelial cells.
The fact that DMBT1 promotes angiogenesis and vascular repair is at odds with the assumption-based on the function of hensin and its presumed role in tumor suppression-that DMBT1 might inhibit cell proliferation and initiate cell differentiation. However, as mentioned previously, DMBT1 may play a more complex role in tumorigenesis than originally thought and that its actions differ from that of a conventional tumor suppressor gene. 3 It is also important to remember that the vascular repair processes studied in the hindlimb are not solely dependent on angiogenesis but also on different subsets of cells of the hematopoietic lineage. The latter promote the vascularization of matrix material and tumors by acting as accessory cells secreting a number of proangiogenic factors and differentiating to form new blood vessels. 25, 26 This is of relevance as DMBT1 is upregulated in stem/progenitor cells during regeneration 4 and was proposed as a bone marrow hepatic stem cell primer in rats subjected to common bile duct ligation. 27 It will be interesting to assess whether or not DMBT1 is expressed in circulating progenitor cells with angiogenic potential (previously referred to as endothelial progenitor cells), or whether its expression affects the recruitment of such cells to sites of injury. To date studies on the role of DMBT1 on tumor development have focused on nonvascular cells, but it remains to be determined to what extent the lack of endothelial cell-derived DMBT1 (and eventually decreased Notch signaling) can contribute to the abnormal organization, structure and altered function (eg, hyper-permeability and heterogeneous blood flow) of tumor vasculature and eventually metastasis.
